Overview

 

MOLOGEN AG develops innovative new drugs and vaccines on the basis of its proprietary platform technologies MIDGE^® and dSLIM^®. Both technologies are based on DNA structures and can be used both therapeutically and prophylactically in numerous medical applications thanks to their special structure and complexity. We focus our research and development activities on illnesses for which there is still strong medical need: the treatment of cancer and severe infectious diseases.

 

 

 

MOLOGEN®, MIDGE® and dSLIM® are registered trademarks of MOLOGEN AG